Symbol
LXEO on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
3.68M shares
Security Ownership
11.1%
Shares, Excluding Options vs Price
Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO)

2025-08-14 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.68M shares of Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO). This represents 11.1% percent ownership of the company. In their previous filing dated 2025-05-14, JANUS HENDERSON GROUP PLC had reported owning 4.56M shares, indicating a decrease of -19.2% percent.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.